Malignant Ascites Treatment Market - Size, Share, Outlook and Opportunity Analysis 2018-2026

1. Malignant Ascites Treatment Market - Size, Share, Malignant Ascites Treatment Market - Size, Share, Outlook and Opportunity Analysis 2018-2026 Outlook and Opportunity Analysis 2018-2026 Ascites is the condition characterized by formation of excessive fluid in the abdominal cavity, particularly in the peritoneal cavity. It causes when the body is unable to eliminate out fluids. When ascites is developed due to cancer, it is called as malignant peritoneal effusion or malignant ascites. Malignancies that are most commonly associated with malignant ascites are cancers of breast, liver, ovary, lungs, lymphoma, and colon. In ascites condition, lymph glands in the body gets blocked and lead to ascites symptoms including low blood pressure, loss of sleep, fatigue, and skin problems. Key symptoms in malignant ascites are abdominal pain or discomfort, shortness of breath, swelling of the abdomen, leg or ankle swelling, constipation, and weight gain. Diagnosis of ascites can be done by ultrasound, x-ray test, CT scans, and physical examination. The survival rate of these patients is very low, although with suitable treatment such as paracentesis, chemotherapy, and surgeries are available. Various conventional treatment for malignant ascites include chemotherapy, shunting, paracentesis, and use of drugs such as spironolactone and spironolactone. Cirrhosis of the liver is the most common cause of ascites but other conditions such as kidney failure, heart failure, cancer or infection can also cause ascites. Download PDF Brochure Of This Research Report @ Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1775 https://www.coherentmarketinsights.com/insight/request-pdf/1775 Malignant Ascites Treatment Market – Dynamics Malignant Ascites Treatment Market – Dynamics Rising prevalence of cirrhosis is a major factor for growth of the malignant ascites market. For instance, according to a study published in World Journal of Gastroenterology 2011, over 50% of patients develop ascites within 10 years diagnosis. According to a published article in Journal of Clinical and Translational Hepatology 2014 showed advancements in ascites condition is related with poor prognosis, with a mortality of 15% at one year and 44% at the five year follow up. Moreover, favorable reimbursement policies like 2010 Patient Protection and Affordable Care Act (PPACA) and increasing incidence of cancer are also propelling the market growth. For instance, according to 2018 American Cancer Society report, cancer was responsible

2. for 609,640 deaths in the U.S. Furthermore, key company adopt market strategies such as acquisition are propelling the market growth, For instance, 2016 NanoAntibiotics acquired LAT Pharma LLC, an early-stage biotechnology company famous for developing new medicines to treat life-threatening complications of liver cirrhosis. However, stringent regulations and complications associated with ascites treatment such as internal bleeding after paracentesis treatment, exposure of radiation in chemotherapy may hinder growth of the market over the forecast period. For instance, According to report published in 2017 Experimental & Molecular Medicine showed that radiation can induce toxicities in non-tumorous liver tissues that may limit the course of therapy or have serious chronic side effects, including late fibrosis. Malignant Ascites Treatment Market – Regional Insights Malignant Ascites Treatment Market – Regional Insights On the basis of region, malignant ascites treatment market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America accounts for the largest share in the global malignant ascites treatment market size, owing to high healthcare expenditure, well-developed technology, and increasing prevalence of cirrhosis are accelerating growth of the malignant ascites treatment market in this region. For instance, according to study published in 2015 Journal of Clinical Gastroenterology showed prevalence of cirrhosis in the U.S. was approximately 0.27%, corresponding to 633,323 adults. Browse For More Information @ Browse For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/malignant-ascites-treatment-market-1775 https://www.coherentmarketinsights.com/ongoing-insight/malignant-ascites-treatment-market-1775 Moreover, Asia Pacific is expected to witness significant growth in the market over the forecast period, owing to increasing prevalence of cirrhosis. For instance, according to a study published in 2015 BMJ Open Gastroenterology, hospitalization from viral hepatitis cirrhosis decreased by 10% between 2006 to 2010, however, non-viral hepatitis cirrhosis and alcoholic cirrhosis exhibited an increase of 35% and 33% in China. Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Malignant Ascites Treatment Market Research Objective and Assumption • Malignant Ascites Treatment Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Malignant Ascites Treatment Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Malignant Ascites Treatment Market, By Regions

3. • Malignant Ascites Treatment Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Malignant Ascites Treatment Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Malignant Ascites Treatment Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Malignant Ascites Treatment Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Malignant Ascites Treatment Market – Competitive Landscape Malignant Ascites Treatment Market – Competitive Landscape Key players operating in the global malignant ascites treatment market include PharmaCyte Biotech Inc., Sequana Medical, Fresenius SE & Co. KGaA, BioVie, BD, Medtronic plc, and GI Supply, Actavis Elizabeth LLC, Mylan Pharmaceuticals Inc., GE Healthcare, Trion Pharma, Siemens AG, and Fresenius Biotech. Major players are focused towards adopting strategies such as collaboration, and increasing R&D funding to strengthen their product portfolio and retain their position in the market, For instance, BioVie’s Lead Compound BIV201 received FDA Orphan-Drug Designation for the treatment of ascites in 2016 Malignant Ascites Treatment Market – Taxonomy Malignant Ascites Treatment Market – Taxonomy On the basis of treatment type, malignant ascites treatment market is segmented into: • Therapeutic Treatment • Surgical Treatment On the basis of application, malignant ascites treatment market is segmented into: • Ovarian Cancer • Breast Cancer • Gastrointestinal Cancer • Colorectal Cancer • Carcinoma of Unknown Primary

4. • Others On the basis of geography, malignant ascites treatment market is segmented into: • North America • Latin America • Europe • Asia Pacific • Middle East • Africa Request For Customization of Research Report @ Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1775 https://www.coherentmarketinsights.com/insight/request-customization/1775 About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com